IQVIA Holdings Inc. (IQV)
After hours:
| Previous Close | 240.65 |
| Open | 237.02 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's Range | 235.75 - 240.36 |
| 52 Week Range | 165.75 - 256.62 |
| Volume | |
| Avg. Volume | 833,650 |
| Market Cap | 44.054B |
| Beta (5Y Monthly) | 1.38 |
| PE Ratio (TTM) | 37.35 |
| EPS (TTM) | 6.35 |
| Earnings Date | Feb 10, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 254.85 |
- Zacks
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?
IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
At US$241, Is IQVIA Holdings Inc. (NYSE:IQV) Worth Looking At Closely?
IQVIA Holdings Inc. ( NYSE:IQV ) received a lot of attention from a substantial price increase on the NYSE over the...
- Business Wire
IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in China
RESEARCH TRIANGLE PARK, N.C., January 31, 2023--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the pharmaceutical and broader life sciences industry, today announces the first life sciences industry collaboration with Alibaba Cloud in China. IQVIA and Alibaba Cloud, the digital technology and intelligence backbone of Alibaba Group, will be providing solutions hosted in Mainland China leveraging Salesforce on Alibaba Clou
